What should readers do when two papers seem to disagree? VIP research in experimental colitis gives a practical answer: read the model before combining the conclusions.
The study favoring inhibition
A 2014 study compared 32 VIP-knockout mice with 14 age-matched wild-type mice in a 2.5% DSS colitis model. VIP deletion was associated with less disease. Separate antagonist experiments also supported reduced colitis and inflammatory signals when VIP activity was inhibited.
The study favoring protection
A 2015 study found baseline intestinal abnormalities in VIP-deficient mice, including barrier-related defects, and worse disease in DSS and DNBS colitis models. VIP treatment reversed several abnormalities. Selected DSS figure groups contained six to seven animals; that count should not be treated as the total for every experiment.
Why this is not a simple yes-or-no question
“Inflammation” can refer to different measurements made at different times. Barrier condition, tissue changes and inflammatory signals should not be collapsed into one score. A result for one of those outcomes may leave another unresolved.
The reports also concern experimental disease in mice. They do not establish whether a supplied VIP research material treats inflammatory bowel disease in people.
A better way to compare the papers
Start with the baseline state, the disease trigger, the timing of intervention and the endpoint. Ask whether the experiments pose the same question. Only then decide whether their results can reasonably be placed alongside each other.
A useful comparison table should leave a blank where a detail has not been checked, rather than assuming it matches. Differences in the setup can be part of the scientific question, not an inconvenience to remove.
What does this mean for research planning?
Specify whether you are testing a barrier effect, a change in inflammation or both. Choose measurements that address each question separately. Include an appropriate comparator and record the condition of the model before the intervention.
For readers, the most honest benefit summary keeps both findings visible. Selecting only the positive-looking paper would hide the uncertainty that makes this topic worth studying.
Related NHD research material
The NHD VIP product page identifies related laboratory catalog options. For a material enquiry, specify the exact identity, quantity, planned assay and required analytical records. Published results do not validate an NHD batch.
Ask NHD about material options and available documents.
Original research
Inhibition of vasoactive intestinal peptide induces resistance to DSS-induced colitis in mice; 2014 · VIP promotes intestinal barrier homeostasis and protection against colitis in mice; 2015. Sources checked 10 October 2026.
AI-assisted editorial review checked study numbers, wording and product links; this is not independent peer review. NHD catalog materials are for laboratory research, development and manufacturing, not human or veterinary use. A catalog material is not a clinical trial medicine or a tested finished formulation.
Sources & editorial method
AI-assisted writing
2 linked records are listed in the references below. Read the editorial and AI-assistance policy.
How to interpret this article
AI-assisted source and readability checks, not independent peer review.
Research-use boundary: Catalog materials discussed on this website are for laboratory research, development and manufacturing use only, not for human or veterinary use. This content is not medical advice and does not provide administration instructions.
Primary records and authoritative sources
Continue with structured records
Move from this editorial analysis to the product identity, filtered evidence and controlled terminology behind it.
